Approvals/CIMA-AEMPS/AKYNZEO 235 MG/0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Approved

STANDARD

AKYNZEO 235 MG/0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Helsinn Birex Pharmaceuticals Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 54837da7b12eb5b1
Drug Cima Aemps Name: AKYNZEO 235 MG/0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Register Number: 1151001003
Holder Company Name: Helsinn Birex Pharmaceuticals Limited
Marketing Company Name: Vifor Pharma Espana S.L.
Holder Company Detail Path: /organization/helsinn-birex-pharmaceuticals-limited
Authorization Date: 2020-06-10
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 235 mg /0,25 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Helsinn Birex Pharmaceuticals Limited
Company Detail Path: /organization/helsinn-birex-pharmaceuticals-limited

FOSNETUPITANT

235 mg

PALONOSETRON HIDROCLORURO

0,28 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 10, 2020

Approval ID

54837da7b12eb5b1

Type

Standard